Progress in defining clinically meaningful changes for clinical trials in nonrenal manifestations of SLE disease activity
about
Switching Between Reference Biologics and Biosimilars for the Treatment of Rheumatology, Gastroenterology, and Dermatology Inflammatory Conditions: Considerations for the Clinician.Comparison of the Sensitivity to Change of the 36-Item Short Form Health Survey and the Lupus Quality of Life Measure Using Various Definitions of Minimum Clinically Important Differences in Patients With Active Systemic Lupus Erythematosus.Analgesic Effect of Moxibustion with Different Temperature on Inflammatory and Neuropathic Pain Mice: A Comparative Study.
P2860
Progress in defining clinically meaningful changes for clinical trials in nonrenal manifestations of SLE disease activity
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Progress in defining clinicall ...... ations of SLE disease activity
@ast
Progress in defining clinicall ...... ations of SLE disease activity
@en
Progress in defining clinicall ...... ations of SLE disease activity
@nl
type
label
Progress in defining clinicall ...... ations of SLE disease activity
@ast
Progress in defining clinicall ...... ations of SLE disease activity
@en
Progress in defining clinicall ...... ations of SLE disease activity
@nl
prefLabel
Progress in defining clinicall ...... ations of SLE disease activity
@ast
Progress in defining clinicall ...... ations of SLE disease activity
@en
Progress in defining clinicall ...... ations of SLE disease activity
@nl
P2860
P3181
P1476
Progress in defining clinicall ...... ations of SLE disease activity
@en
P2093
Matthew H Liang
P2860
P2888
P3181
P356
10.1186/S13075-015-0906-9
P407
P5008
P577
2016-01-06T00:00:00Z
P5875
P6179
1005700906